Russell Investments Group, Ltd. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 78 filers reported holding NEOS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 21.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$874,000580,391
+290095.5%
0.00%
Q2 2019$0
-100.0%
200
-99.9%
0.00%
-100.0%
Q3 2018$1,875,000
-51.3%
386,962
-37.1%
0.00%
-50.0%
Q2 2018$3,848,000
-44.1%
615,674
-25.8%
0.01%
-33.3%
Q1 2018$6,884,000
+38.3%
829,298
+65.8%
0.01%
+50.0%
Q4 2017$4,976,000
+98.5%
500,170
+82.5%
0.01%
+100.0%
Q3 2017$2,507,000
+27.2%
274,087
+1.5%
0.00%0.0%
Q2 2017$1,971,000
+171.9%
270,020
+167.9%
0.00%
+300.0%
Q1 2017$725,000
+33.0%
100,783
+15.5%
0.00%0.0%
Q4 2016$545,00087,2560.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders